Damora Therapeutics, Inc.
DMRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001800315
In the last 90 days, Damora Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 104 institutions reported holding it in 13F filings for Q2 2026, worth $1.67B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in Damora Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 10
- −11 vs. Q2 2024
- Shares held
- 128.6K
- −32.0K (−19.9%) vs. Q2 2024Converted for a 1-for-25 split
- Total value
- $1.56M
- −$341.1K (−17.9%) vs. Q2 2024
- New holders
- 3
- 3 more added
- Sold out
- 14
- 1 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 104 | $1.67B |
| Q1 2026 | 65 | $1.45B |
| Q4 2025 | 18 | $65.5M |
| Q3 2025 | 12 | $633.3K |
| Q2 2025 | 9 | $451.5K |
| Q1 2025 | 11 | $442.4K |
| Q4 2024 | 10 | $660.7K |
| Q3 2024 | 10 | $1.56M |
| Q2 2024 | 22 | $1.91M |
| Q1 2024 | 26 | $3.09M |
| Q4 2023 | 22 | $2.77M |
| Q3 2023 | 22 | $3.92M |
| Q2 2023 | 27 | $25.7M |
| Q1 2023 | 26 | $17.8M |
| Q4 2022 | 22 | $10.2M |
| Q3 2022 | 26 | $17.3M |
| Q2 2022 | 23 | $15.7M |
| Q1 2022 | 25 | $21.0M |
| Q4 2021 | 26 | $30.5M |
| Q3 2021 | 25 | $37.2M |
| Q2 2021 | 27 | $57.4M |
| Q1 2021 | 19 | $82.9M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Damora Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Novo Holdings A/S | 99,913 | $1.21M | 0.06% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Renaissance Technologies LLC | 21,382 | $259.8K | 0.00% | −1,790−7.7% | ReducedConverted for a 1-for-25 split |
| UBS Group AG | 5,099 | $62.0K | 0.00% | +5,099 | New |
| Bank of America Corp | 1,225 | $14.9K | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| BlackRock, Inc. | 490 | $5.95K | 0.00% | +490 | New |
| Tower Research Capital LLC (TRC) | 346 | $4.20K | 0.00% | +205+145.9% | AddedConverted for a 1-for-25 split |
| Morgan Stanley | 160 | $1.94K | 0.00% | +40+33.3% | AddedConverted for a 1-for-25 split |
| Harbour Investments, Inc. | 8 | $97 | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Danske Bank A/S | 7 | $85 | 0.00% | +7 | New |
| Group One Trading, L.P. | 3 | $37 | 0.00% | +0+10.3% | AddedConverted for a 1-for-25 split |
| Vanguard Group Inc | 0 | $0 | 0.00% | −8,848−100.0% | Sold outConverted for a 1-for-25 split |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −8,565−100.0% | Sold outConverted for a 1-for-25 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −6,734−100.0% | Sold outConverted for a 1-for-25 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −5,143−100.0% | Sold outConverted for a 1-for-25 split |
| State Street Corp | 0 | $0 | 0.00% | −1,796−100.0% | Sold outConverted for a 1-for-25 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −1,426−100.0% | Sold outConverted for a 1-for-25 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −1,085−100.0% | Sold outConverted for a 1-for-25 split |
| Summit Trail Advisors, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold outConverted for a 1-for-25 split |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −641−100.0% | Sold outConverted for a 1-for-25 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −587−100.0% | Sold outConverted for a 1-for-25 split |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −118−100.0% | Sold outConverted for a 1-for-25 split |
| Spire Wealth Management | 0 | $0 | 0.00% | −81−100.0% | Sold outConverted for a 1-for-25 split |
| Royal Bank of Canada | 0 | $0 | 0.00% | −8−100.0% | Sold outConverted for a 1-for-25 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −26−100.0% | Sold outConverted for a 1-for-25 split |
| BlackRock Inc. | – | – | – | – | Not filed |